Determinants of Paucibacillary Mtb Infection in Mice
小鼠少杆菌 Mtb 感染的决定因素
基本信息
- 批准号:10268807
- 负责人:
- 金额:$ 45.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAftercareAgarAlveolar MacrophagesB-LymphocytesBiological MarkersBiological Response ModifiersBiotinBloodCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCellsChronicClinicalColony-forming unitsDexamethasoneDiseaseEnvironmentEssential GenesFirst Independent Research Support and Transition AwardsGenesHumanImmuneImmunityImmunophenotypingImmunosuppressionInfectionIntegration Host FactorsLeukocytesLigaseMeasuresMessenger RNAModelingMouse StrainsMusMycobacterium tuberculosisNatural Killer CellsPatientsPharmacologyPhysiologicalPopulationPredispositionProteinsRecurrent diseaseRegulonRelapseSCID MiceSymptomsT-LymphocyteTestingTimeTuberculosischemotherapychronic infectiondisorder riskhigh riskimmunopathologyin vivoinsightinterstitialmacrophagemouse modelmutantpreventrelapse predictionrelapse riskthioredoxin reductasetranscriptometranscriptomicstuberculosis chemotherapy
项目摘要
Tuberculosis (TB) chemotherapy eliminates disease symptoms, but often fails to sterilize Mycobacterium
tuberculosis (Mtb) leaving apparently cured TB patients at risk of disease relapse. How Mtb survives during post-
treatment persistent infections (PTPI) is ill defined and we lack a full understanding of the immune determinants
that prevent progression to active TB (relapse).
We developed a paucibacillary (low bacterial numbers) mouse model that mimics PTPI in in humans. We found
that silencing of in vivo essential genes cured Mtb infections in mice to the extent that colony forming units (CFU)
were no longer detected on agar plates. However, as in humans, mice were often not sterilized, and
paucibacillary infection resulted in relapse TB. Our model allows us to interrogate both, the mechanisms that
enable Mtb to persist despite host immunity and the host factors that are required to control and sterilize Mtb
infection. We will use this model to (1) compare post-treatment persistent infection (PTPI) in mice and humans
(2) determine the importance of specific leukocyte subsets for the establishment or control of paucibacillary Mtb
infection and (3) identify Mtb genes that are required for paucibacillary persistence.
结核病(TB)化疗消除了疾病症状,但往往无法杀灭分枝杆菌
结核病(Mtb)使明显治愈的结核病患者面临疾病复发的风险。结核杆菌如何在感染后存活
治疗持续性感染(PTPI)是不明确的,我们缺乏对免疫决定因素的全面了解
预防进展为活动性结核病(复发)。
我们开发了一种模拟人类PTPI的少杆菌(低细菌数量)小鼠模型。我们发现
体内必需基因的沉默治愈了小鼠中的结核分枝杆菌感染,
在琼脂平板上不再检测到。然而,与人类一样,小鼠通常没有绝育,
少杆菌感染导致结核病复发。我们的模型允许我们询问两者,
使结核分枝杆菌能够持续存在,尽管宿主免疫力和宿主因素是控制和消灭结核分枝杆菌所必需的
感染我们将使用该模型来(1)比较小鼠和人类的治疗后持续感染(PTPI)
(2)确定特定白细胞亚群对建立或控制少杆菌型Mtb的重要性
感染和(3)鉴定少杆菌持久性所需的Mtb基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SABINE EHRT其他文献
SABINE EHRT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SABINE EHRT', 18)}}的其他基金
M. tuberculosis carbon metabolism during infection
结核分枝杆菌感染期间的碳代谢
- 批准号:
10716619 - 财政年份:2023
- 资助金额:
$ 45.99万 - 项目类别:
Turning Mycobacterium tuberculosis appetite for fatty acids against itself
结核分枝杆菌对脂肪酸的需求与自身相悖
- 批准号:
10592602 - 财政年份:2022
- 资助金额:
$ 45.99万 - 项目类别:
Determinants of TB control, relapse and reinfection
结核病控制、复发和再感染的决定因素
- 批准号:
10268801 - 财政年份:2021
- 资助金额:
$ 45.99万 - 项目类别:
Determinants of TB control, relapse and reinfection
结核病控制、复发和再感染的决定因素
- 批准号:
10621299 - 财政年份:2021
- 资助金额:
$ 45.99万 - 项目类别:
Determinants of Paucibacillary Mtb Infection in Mice
小鼠少杆菌 Mtb 感染的决定因素
- 批准号:
10430228 - 财政年份:2021
- 资助金额:
$ 45.99万 - 项目类别:
Determinants of TB control, relapse and reinfection
结核病控制、复发和再感染的决定因素
- 批准号:
10430221 - 财政年份:2021
- 资助金额:
$ 45.99万 - 项目类别:
Determinants of Paucibacillary Mtb Infection in Mice
小鼠少杆菌 Mtb 感染的决定因素
- 批准号:
10621309 - 财政年份:2021
- 资助金额:
$ 45.99万 - 项目类别:
相似海外基金
Life outside institutions: histories of mental health aftercare 1900 - 1960
机构外的生活:1900 - 1960 年心理健康善后护理的历史
- 批准号:
DP240100640 - 财政年份:2024
- 资助金额:
$ 45.99万 - 项目类别:
Discovery Projects
Development of a program to promote psychological independence support in the aftercare of children's homes
制定一项计划,促进儿童之家善后护理中的心理独立支持
- 批准号:
23K01889 - 财政年份:2023
- 资助金额:
$ 45.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
- 批准号:
10452217 - 财政年份:2022
- 资助金额:
$ 45.99万 - 项目类别:
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
- 批准号:
10670838 - 财政年份:2022
- 资助金额:
$ 45.99万 - 项目类别:
Aftercare for young people: A sociological study of resource opportunities
年轻人的善后护理:资源机会的社会学研究
- 批准号:
DP200100492 - 财政年份:2020
- 资助金额:
$ 45.99万 - 项目类别:
Discovery Projects
Creating a National Aftercare Strategy for Survivors of Pediatric Cancer
为小儿癌症幸存者制定国家善后护理策略
- 批准号:
407264 - 财政年份:2019
- 资助金额:
$ 45.99万 - 项目类别:
Operating Grants
Aftercare of green infrastructure: creating algorithm for resolving human-bird conflicts
绿色基础设施的善后工作:创建解决人鸟冲突的算法
- 批准号:
18K18240 - 财政年份:2018
- 资助金额:
$ 45.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an aftercare model for children who have experienced invasive procedures
为经历过侵入性手术的儿童开发善后护理模型
- 批准号:
17K12379 - 财政年份:2017
- 资助金额:
$ 45.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a Comprehensive Aftercare Program for children's self-reliance support facility
为儿童自力更生支持设施制定综合善后护理计划
- 批准号:
17K13937 - 财政年份:2017
- 资助金额:
$ 45.99万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Project#2 Extending Treatment Effects Through an Adaptive Aftercare Intervention
项目
- 批准号:
8742767 - 财政年份:2014
- 资助金额:
$ 45.99万 - 项目类别: